NRXP
NASDAQ · Pharmaceuticals
Nrx Pharmaceuticals Inc
$3.08
+0.02 (+0.65%)
Open$3.08
Previous Close$3.06
Day High$3.13
Day Low$3.01
52W High$3.84
52W Low$1.62
Volume—
Avg Volume892.6K
Market Cap101.85M
P/E Ratio—
EPS$-1.57
SectorPharmaceuticals
Analyst Ratings
Strong Buy
10 analysts
Price Target
+590.9% upside
Current
$3.08
$3.08
Target
$21.28
$21.28
$14.65
$21.28 avg
$27.46
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.89M | 21.55M | 19.28M |
| Net Income | -44,081,526 | 2.70M | 1.92M |
| Profit Margin | -2,336.5% | 12.5% | 10.0% |
| EBITDA | -42,904,832 | 4.73M | 4.55M |
| Free Cash Flow | — | 2.93M | 1.59M |
| Rev Growth | — | +2.0% | +3.7% |
| Debt/Equity | 1.42 | 0.67 | 0.51 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |